News Release 09-069
"Two-handed" Marine Microbes Point to New Method for Isolating Harmful Forms of Chemicals
Major impact envisioned for pharmaceutical, food, agriculture industries
April 15, 2009
This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.
Scientists studying how marine bacteria move have discovered that a sharp variation in water current segregates right-handed bacteria from their left-handed brethren, impelling the microbes in opposite directions.
This finding and the possibility of quickly and cheaply implementing the segregation of two-handed objects in the laboratory could have a big impact on industries like the pharmaceutical industry, for which the separation of right-handed from left-handed molecules can be crucial to drug safety.
"This is a remarkable example of how basic research, initially focused on understanding how bacteria interact with their environment, can lead to discoveries far beyond that envisioned," said David Garrison, director of the National Science Foundation (NSF)'s Biological Oceanography Program, which funded the research.
While single-celled bacteria do not have hands, their helical-shaped flagella spiral either clockwise or counter-clockwise, making opposite-turning flagella similar to human hands in that they create mirror images of one another.
This two-handed quality is called chirality, and in a molecule, it can make the difference between healing and harming the human body.
"This discovery could impact our understanding of how water currents affect ocean microbes, particularly with respect to their ability to forage for food, since chiral effects make them drift off-course," said Roman Stocker, a marine scientist at MIT and lead investigator on the research project. "But it is also important for several industries that rely on the ability to separate two-handed molecules."
Stocker and graduate student Marcos, along with co-authors Henry Fu and Thomas Powers of Brown University, published their findings in the April 17 issue of the journal Physical Review Letters.
One of the best-known instances of a chiral molecule causing widespread harm occurred in the 1950s, when the drug thalidomide was given to pregnant women to prevent morning sickness.
One naturally occurring form--or isomer--of thalidomide reduces nausea; the other causes birth defects. In another commonly used chiral drug, naproxen, one isomer is analgesic; the other causes liver damage.
In their paper, the researchers describe how they designed a microfluidic environment--a device about the size of an iPod nano that has channels containing water and bacteria--to create a "shear" flow of layers of water moving at different speeds.
In their tests, Stocker and Marcos used a non-motile mutant of the bacterium Leptospira biflexa, whose entire body has the shape of a right-handed helix.They injected the Leptospira into the center of the microfluidic device and demonstrated that the bacteria drift off-course in a direction dictated by their chirality.
The researchers also developed a mathematical model of the process, and are implementing this new approach to separate objects at molecular scales.
"The methods currently used to separate chiral molecules are far more expensive and far slower than the microfluidic option," said Marcos.
"While we still have a way to go to separate actual chiral molecules, we think our work is very promising for the agriculture, food and pharmaceutical industries."
Experiments on marine bacteria have been conducted using this microfluidic research set-up.
Credit and Larger Version
The bacterium Leptospira biflexa has new information for pharmaceutical, other industries.
Credit and Larger Version
The U.S. National Science Foundation propels the nation forward by advancing fundamental research in all fields of science and engineering. NSF supports research and people by providing facilities, instruments and funding to support their ingenuity and sustain the U.S. as a global leader in research and innovation. With a fiscal year 2022 budget of $8.8 billion, NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and institutions. Each year, NSF receives more than 40,000 competitive proposals and makes about 11,000 new awards. Those awards include support for cooperative research with industry, Arctic and Antarctic research and operations, and U.S. participation in international scientific efforts.